Exposure to cigarette smoke abrogates the beneficial effect of ischemic postconditioning

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 311, Issue 5, 2016, Pages H1321-H1332

  Bibli, Sofia Iris ^a   Andreadou, Ioanna ^a   Glynos, Constantinos ^a   Chatzianastasiou, Athanasia ^a   Toumpanakis, Dimitris ^a   Zakynthinos, Spyros ^a   Vasilakopoulos, Theodoros ^a   Iliodromitis, Efstathios K ^b   Papapetropoulos, Andreas ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

cGMP; Cigarette smoke; Conditioning; eNOS; Infarct size

Indexed keywords

CIGARETTE SMOKE; CYCLIC GMP; GUANYLATE CYCLASE; NITRIC OXIDE SYNTHASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; INTERLEUKIN-6, MOUSE; MESSENGER RNA; NOS3 PROTEIN, MOUSE; PROTEIN KINASE B; SMOKE; TUMOR NECROSIS FACTOR;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELEVATED BLOOD PRESSURE; HEART INFARCTION SIZE; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; INTRACELLULAR SIGNALING; ISCHEMIC POSTCONDITIONING; MALE; MOUSE; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; UPREGULATION; ANIMAL; BLOOD PRESSURE; CARDIAC MUSCLE; CARDIOMEGALY; DISEASE MODEL; HEART INFARCTION; HEART INFARCTION PREVENTION; HYPERTENSION; METABOLISM; PATHOLOGY; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKE; TOBACCO; WESTERN BLOTTING;

ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; CARDIOMEGALY; CYCLIC GMP; DISEASE MODELS, ANIMAL; HYPERTENSION; INTERLEUKIN-6; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MICE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMOKE; TOBACCO; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84994663337     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00925.2015     Document Type: Article

References (56)

1. Andreadou I, Farmakis D, Prokovas E, Sigala F, Zoga A, Spyridaki K, Papalois A, Papapetropoulos A, Anastasiou-Nana M, Kremastinos DT, Iliodromitis EK. Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress. Cardiovasc Res 94: 501-509, 2012.
2. Andreadou I, Mikros E, Ioannidis K, Sigala F, Naka K, Kostidis S, Farmakis D, Tenta R, Kavantzas N, Bibli SI, Gikas E, Skaltsounis L, Kremastinos DT, Iliodromitis EK. Oleuropein prevents doxorubicininduced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism. J Mol Cell Cardiol 69: 4-16, 2014.
3. Andreadou I, Iliodromitis EK, Rassaf T, Schulz R, Papapetropoulos A, Ferdinandy P. The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning. Br J Pharmacol 172: 1587-1606, 2015.
4. Arunachalam G, Yao H, Sundar IK, Caito S, Rahman I. SIRT1 regulates oxidant-and cigarette smoke-induced eNOS acetylation in endothelial cells: role of resveratrol. Biochem Biophys Res Commun 393: 66-72, 2010.
5. Barsukevich V, Basalay M, Sanchez J, Mrochek A, Whittle J, Ackland GL, Gourine AV, Gourine A. Distinct cardioprotective mechanisms of immediate, early and delayed ischaemic postconditioning. Basic Res Cardiol 110: 452, 2015.
6. Barua RS, Ambrose JA, Srivastava S, DeVoe MC, Eales-Reynolds LJ. Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: an in vitro demonstration in human coronary artery endothelial cells. Circulation 107: 2342-2347, 2003.
7. Bibli SI, Andreadou I,. Chatzianastasiou A, Tzimas C, Sanoudou D, Kranias E, Brouckaert P, Coletta C, Szabo C, Kremastinos DT, Iliodromitis EK, Papapetropoulos A. Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway. Cardiovasc Res 106: 432-442, 2015.
8. Boengler K, Buechert A, Heinen Y, Roeskes C, Hilfiker-Kleiner D, Heusch G, Schulz R. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res 102: 131-135, 2008.
9. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with doserelated and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88: 2149-2155, 1993.
10. Cohen MV, Downey JM. Signalling pathways and mechanisms of protection in pre-and postconditioning: historical perspective and lessons for the future. Br J Pharmacol 172: 1913-1932, 2015.
11. D’Hulst AI, Maes T, Bracke KR, Demedts IK, Tournoy KG, Joos GF, Brusselle GG. Cigarette smoke-induced pulmonary emphysema in scidmice. Is the acquired immune system required? Respir Res 6: 147, 2005.
12. Dumitrescu C, Biondi R, Xia Y, Cardounel AJ, Druhan LJ, Ambrosio G, Zweier JL. Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH 4. Proc Natl Acad Sci USA 104: 15081-15086, 2007.
13. Fantinelli JC, Mosca SM. Comparative effects of ischemic pre and postconditioning on ischemia-reperfusion injury in spontaneously hypertensive rats (SHR). Mol Cell Biochem 296: 45-51, 2007.
14. Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R. Interaction of risk factors, comorbidities, and comedications with ischemia/ reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev 66: 1142-1174, 2014.
15. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. Regulation of endotheliumderived nitric oxide production by the protein kinase Akt. Nature 399: 597-601, 1999.
16. Garcia-Dorado D, Agullo L, Sartorio CL, Ruiz-Meana M. Myocardial protection against reperfusion injury: the cGMP pathway. Thromb Haemost 101: 635-642, 2009.
17. Gfroerer J, Dube SR, King BA, Garrett BE, Babb S, McAfee T. Vital signs: current cigarette smoking among adults aged ≥18 years with mental illness-United States, 2009-2011. MMWR Morb Mortal Wkly Rep 62: 81-87, 2013.
18. Guo X, Oldham MJ, Kleinman MT, Phalen RF, Kassab GS. Effect of cigarette smoking on nitric oxide, structural, and mechanical properties of mouse arteries. Am J Physiol Heart Circ Physiol 291: H2354-H2361, 2006.
19. Hahn JY, Song YB, Kim EK, Yu CW, Bae JW, Chung WY, Choi SH, Choi JH, Bae JH, An KJ, Park JS, Oh JH, Kim SW, Hwang JY, Ryu JK, Park HS, Lim DS, Gwon HC. Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial. Circulation 128: 1889-1896, 2013.
20. Hausenloy DJ, Yellon DM. The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol 8: 619-629, 2011.
21. Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 123: 92-100, 2013.
22. Hernández-Reséndiz S, Roldán FJ, Correa F, Martínez-Abundis E, Osorio-Valencia G, Ruíz-de-Jesús O, Alexánderson-Rosas E, Vigueras RM, Franco M, Zazueta C. Postconditioning protects against reperfusion injury in hypertensive dilated cardiomyopathy by activating MEK/ ERK1/2 signaling. J Card Fail 19: 135-146, 2013.
23. Heusch G. Reduction of infarct size by ischaemic post-conditioning in humans: fact or fiction? Eur Heart J 33: 13-15, 2012.
24. Hozawa A, Okamura T, Murakami Y, Kadowaki T, Nakamura K, Hayakawa T, Kita Y, Nakamura Y, Abbott RD, Okayama A, Ueshima H; NIPPONDATA80 Research Group. Joint impact of smoking and hypertension on cardiovascular disease and all-cause mortality in Japan: NIPPON DATA80, a 19-Year Follow-UP. Hypertens Res 30: 1169-1175, 2007.
25. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 378: 1297-305, 2011.
26. Iliodromitis EK, Cohen MV, Dagres N, Andreadou I, Kremastinos DT, Downey JM. What is wrong with cardiac conditioning? We may be shooting at moving targets. J Cardiovasc Pharmacol Ther 20: 357-369, 2015.
27. Inserte J, Hernando V, Vilardosa U, Abad E, Poncelas-Nozal M, Garcia-Dorado D. Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling. J Am Heart Assoc 2: e005975, 2013.
28. Jones SP, Bolli R. The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 40: 16-23, 2006.
29. Khanna AK, Xu J, Mehra MR. Antioxidant N-acetyl cysteine reverses cigarette smoke-induced myocardial infarction by inhibiting inflammation and oxidative stress in a rat model. Lab Invest 92: 224-235, 2012.
30. Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol 34: 509-515, 2014.
31. Mount PF, Kemp BE, Power DA. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol 42: 271-279, 2007.
32. Nemr R, Lasserre B, Chahine R. Effects of nicotine on thromboxane/ prostacyclin balance in myocardial ischemia. Prostaglandins Leukot Essent Fatty Acids 68: 191-195, 2003.
33. Penna C, Mancardi D, Rastaldo R, Pagliaro P. Cardioprotection: a radical view. Free radicals in pre and postconditioning. Biochim Biophys Acta 1787: 781-793, 2009.
34. Penna C, Tullio F, Moro F, Folino A, Merlino A, Pagliaro P. Effects of a protocol of ischemic postconditioning and/or captopril in hearts of normotensive and hypertensive rats. Basic Res Cardiol 105: 181-92, 2010.
35. Penna C, Tullio F, Perrelli MG, Moro F, Abbadessa G, Piccione F, Carriero V, Racca S, Pagliaro P. Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats. Basic Res Cardiol 106: 409-20, 2011.
36. Polhemus DJ, Lefer DJ. Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease. Circ Res 114: 730-737, 2014.
37. Przyklenk K. Nicotine exacerbates postischemic contractile dysfunction of “stunned” myocardium in the canine model. Possible role of free radicals. Circulation 89: 1272-1281, 1994.
38. Qian J, Fulton D. Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium. Front Physiol 4: 347, 2013.
39. Quillen JE, Rossen JD, Oskarsson HJ, Minor RL Jr, Lopez AG, Winniford MD. Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. J Am Coll Cardiol 22: 642-647, 1993.
40. Schror K, Zimmermann KC, Tannhauser R. Augmented myocardial ischaemia by nicotine-mechanisms and their possible significance. Br J Pharmacol 125: 79-86, 1998.
41. Sloth AD, Schmidt MR, Munk K, Schmidt M, Pedersen L, Sørensen HT, Bøtker HE; CONDI Investigators. Impact of cardiovascular risk factors and medication use on the efficacy of remote ischaemic conditioning: post hoc subgroup analysis of a randomised controlled trial. BMJ Open 5: e006923, 2015.
42. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L’Huillier I, Aupetit JF, Bonnefoy E, Finet G, André-Fouët X, Ovize M. Postconditioning the human heart. Circulation 112: 2143-2148, 2005.
43. Stefanadis C, Tsiamis E, Vlachopoulos C, Stratos C, Toutouzas K, Pitsavos C, Marakas S, Boudoulas H, Toutouzas P. Unfavorable effect of smoking on the elastic properties of the human aorta. Circulation 95: 31-38, 1997.
44. Sun J, Aponte AM, Kohr MJ, Tong G, Steenbergen C, Murphy E. Essential role of nitric oxide in acute ischemic preconditioning: S-nitros(yl)-ation versus sGC/cGMP/PKG signaling? Free Radic Biol Med 54: 105-112, 2013.
45. Sun Y, Wang K, Li MX, He W, Chang JR, Liao CC, Lin F, Qi YF, Wang R, Chen YH. Metabolic changes of H2S in smokers and patients of COPD which might involve in inflammation, oxidative stress and steroid sensitivity. Sci Rep 5: 14971, 2015.
46. Talukder MA, Johnson WM, Varadharaj S, Lian J, Kearns PN, El-Mahdy MA, Liu X, Zweier JL. Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice. Am J Physiol Heart Circ Physiol 300: H388-H396, 2011.
47. Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, Cung TT, Bonnefoy E, Angoulvant D, Aupetit JF, Finet G, André-Fouët X, Macia JC, Raczka F, Rossi R, Itti R, Kirkorian G, Derumeaux G, Ovize M. Long-term benefit of postconditioning. Circulation 117: 1037-1044, 2008.
48. Tirziu D, Chorianopoulos E, Moodie KL, Palac RT, Zhuang ZW, Tjwa M, Roncal C, Eriksson U, Fu Q, Elfenbein A, Hall AE, Carmeliet P, Moons L, Simons M. Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice. J Clin Invest 117: 3188-3197, 2007.
49. Wagner L, Laczy B, Tamasko M, Mazak I, Marko L, Molnar GA, Wagner Z, Mohás M, Cseh J, Fekete A, Wittmann I. Cigarette smoke-induced alterations in endothelial nitric oxide synthase phosphorylation: role of protein kinase C. Endothelium 14: 245-255, 2007.
50. Wagner C, Ebner B, Tillack D, Strasser RH, Weinbrenner C. Cardioprotection by ischemic postconditioning is abrogated in hypertrophied myocardium of spontaneously hypertensive rats. J Cardiovasc Pharmacol 61: 35-41, 2013.
51. Wang R. Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol Rev 92: 791-896, 2012.
52. Yamada S, Zhang XQ, Kadono T, Matsuoka N, Rollins D, Badger T, Rodesch CK, Barry WH. Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations. Toxicol Appl Pharmacol 236: 71-77, 2009.
53. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, Snyder SH, Wang R. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine-lyase. Science 322: 587-590, 2008.
54. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 357: 1121-1135, 2007.
55. Zhou X, Li C, Xu W, Chen J. Trimetazidine protects against smokinginduced left ventricular remodeling via attenuating oxidative stress, apoptosis, and inflammation. PLoS One 7: e40424, 2012.
56. Zhu BQ, Sun YP, Sievers RE, Glantz SA, Parmley WW, Wolfe CL. Exposure to environmental tobacco smoke increases myocardial infarct size in rats. Circulation 89: 1282-1290, 1994.